MATV Stock Analysis: Mativ Holdings | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 410m USD | 12M Return: 3.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.15M
EPS Trend: -71.2%
Qual. Beats: 0
Rev. Trend: -68.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Mativ Holdings, Inc. is a U.S.-based specialty materials manufacturer that operates across two reportable segments: Filtration & Advanced Materials and Sustainable & Adhesive Solutions. The companys products, which include engineered polymer and fiber-based substrates, nonwovens, films, adhesive tapes, tapes, labels, liners, and specialty papers, serve a broad range of end-markets such as transportation, water and air filtration, construction, healthcare, industrial, personal care, and consumer goods. The company sells its products in the United States, Europe, the Asia Pacific, the Americas, and other international markets.
The business operates within the GICS Materials sector (Paper Products sub-industry) and follows a B2B model, supplying components and substrates to other manufacturers rather than selling finished consumer goods directly. Its diversified portfolio spans both industrial applications, such as filtration media, protective substrates, and performance labels, and consumer-adjacent end uses, including wound care, stationery, craft papers, and wallpaper.
Mativ Holdings was incorporated in 1995 and is headquartered in Alpharetta, Georgia. The company was formerly known as Schweitzer-Mauduit International, Inc., adopting its current name in July 2022 following the combination of SWM and Neenah, which expanded its paper and packaging footprint alongside its legacy specialty materials operations.
- Filtration segment margins compressed by raw material inflation
- Construction and infrastructure demand boosts adhesive tapes revenue
- Neenah integration synergies support debt reduction and margin expansion
| Net Income: 76.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.03 > 1.0 |
| NWC/Revenue: 18.71% < 20% (prev 20.25%; Δ -1.54% < -1%) |
| CFO/TA 0.07 > 3% & CFO 150.7m > Net Income 76.4m |
| Net Debt (1.08b) to EBITDA (192.7m): 5.60 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.8m) vs 12m ago 0.70% < -2% |
| Gross Margin: 17.32% > 18% (prev 17.94%; Δ -0.62% > 0.5%) |
| Asset Turnover: 96.98% > 50% (prev 95.78%; Δ 1.20% > 0%) |
| Interest Coverage Ratio: 0.76 > 6 (EBIT TTM 51.2m / Interest Expense TTM 67.5m) |
| A: 0.18 (Total Current Assets 664.9m - Total Current Liabilities 294.1m) / Total Assets 2.03b |
| B: -0.10 (Retained Earnings -213.2m / Total Assets 2.03b) |
| C: 0.03 (EBIT TTM 51.2m / Avg Total Assets 2.04b) |
| D: 0.30 (Book Value of Equity 472.3m / Total Liabilities 1.56b) |
| Altman-Z'' = 1.34 = BB |
| DSRI: 0.97 (Receivables 217.0m/221.1m, Revenue 1.98b/1.97b) |
| GMI: 1.04 (GM 17.94% / 17.32%) |
| AQI: 1.06 (AQ_t 0.35 / AQ_t-1 0.33) |
| SGI: 1.01 (Revenue 1.98b / 1.97b) |
| TATA: -0.04 (NI 76.4m - CFO 150.7m) / TA 2.03b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 7.43 with a total of 790,617 shares traded. Over the past week, the price has changed by -1.85%, over one month by -1.72%, over three months by -10.68% and over the past year by +3.88%.
Current recommended Stop Loss: 6.90 (which is 7.1% or 1.3 ATR below the current price).
Mativ Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy MATV.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21 | 182.6% |
P/E Trailing = 5.2766
P/E Forward = 8.9047
P/S = 0.2069
P/B = 1.0713
P/EG = 3.5625
Revenue TTM = 1.98b USD
EBIT TTM = 51.2m USD
EBITDA TTM = 192.7m USD
Long Term Debt = 1.03b USD (from longTermDebt, last quarter)
Short Term Debt = 12.2m USD (from shortTermDebt, last quarter)
Debt = 1.16b USD (from shortLongTermDebtTotal, last quarter) + Leases 63.1m
Net Debt = 1.08b USD (calculated: Debt 1.16b - CCE 82.3m)
Enterprise Value = 1.49b USD (410.1m + Debt 1.16b - CCE 82.3m)
Interest Coverage Ratio = 0.76 (Ebit TTM 51.2m / Interest Expense TTM 67.5m)
EV/FCF = 12.82x (Enterprise Value 1.49b / FCF TTM 116.2m)
FCF Yield = 7.80% (FCF TTM 116.2m / Enterprise Value 1.49b)
FCF Margin = 5.86% (FCF TTM 116.2m / Revenue TTM 1.98b)
Net Margin = 3.86% (Net Income TTM 76.4m / Revenue TTM 1.98b)
Gross Margin = 17.32% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.64b) / Revenue TTM)
Gross Margin QoQ = 14.37% (prev 15.40%)
Tobins Q-Ratio = 0.73 (Enterprise Value 1.49b / Total Assets 2.03b)
Interest Expense / Debt = 5.81% (Interest Expense 67.5m / Debt 1.16b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 40.4m (EBIT 51.2m * (1 - 21.00%))
Current Ratio = 2.26 (Total Current Assets 664.9m / Total Current Liabilities 294.1m)
Debt / Equity = 2.46 (Debt 1.16b / totalStockholderEquity, last quarter 472.3m)
Debt / EBITDA = 5.60 (Net Debt 1.08b / EBITDA 192.7m)
Debt / FCF = 9.29 (Net Debt 1.08b / FCF TTM 116.2m)
Total Stockholder Equity = 446.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.74% (Net Income 76.4m / Total Assets 2.03b)
RoE = 17.12% (Net Income TTM 76.4m / Total Stockholder Equity 446.2m)
RoCE = 3.46% (EBIT 51.2m / Capital Employed (Equity 446.2m + L.T.Debt 1.03b))
RoIC = 2.42% (NOPAT 40.4m / Invested Capital 1.67b)
WACC = 7.14% (E(410.1m)/V(1.57b) * Re(14.37%) + D(1.16b)/V(1.57b) * Rd(5.81%) * (1-Tc(0.21)))
Discount Rate = 14.37% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 73.33 | Cagr: 0.27%
[DCF] Terminal Value 77.97% ; FCFF base≈83.6m ; Y1≈95.8m ; Y5≈141.0m
[DCF] Fair Price = 18.90 (EV 2.12b - Net Debt 1.08b = Equity 1.04b / Shares 55.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -71.19 | EPS CAGR: -30.17% | SUE: 0.37 | # QB: 0
Revenue Correlation: -68.28 | Revenue CAGR: -3.86% | SUE: -0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.28 | Chg30d=-17.65% | Revisions=-25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=-10.53% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.85 | Chg30d=-10.99% | Revisions=-40% | GrowthEPS=+21.4% | GrowthRev=+1.2%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=-0.79% | Revisions=-25% | GrowthEPS=+47.1% | GrowthRev=+3.2%